Clinical trials recruiting for Urinary Bladder Neoplasms
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Carboplatin | 1 |
| Cisplatin | 1 |
| HTL0039732 Capsules | 1 |
| HTL0039732 Capsules and atezolizumab infusion | 1 |
| Pembrolizumab | 1 |
| Sigvotatug Vedotin | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alaska | 1 |
| Arkansas | 1 |
| California | 1 |
| Florida | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Kansas | 1 |
| Massachusetts | 1 |
| Minnesota | 1 |
| Nevada | 1 |
| New York | 1 |
| Ohio | 1 |
Top cities
Self-screener
Recruiting trials
- A Study of Sigvotatug Vedotin in Advanced Solid Tumors
- Benchmarking Large Language Models Against Tumour Boards for Oncology Treatment Recommendations
- HTL0039732 in Participants With Advanced Solid Tumours
- Lymphedema After Urologic Surgery
Related conditions
Trials recruiting for Urinary Bladder Neoplasms often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Urinary Bladder Neoplasms trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.